Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Scanning Electron Microscopy
100%
Atherosclerosis
100%
Plasminogen Activator Inhibitor 1
100%
Normal Human
50%
Base
50%
Fibrinolytic Agent
50%
Thrombosis
50%
Atherogenesis
50%
Tissue Plasminogen Activator
50%
Keyphrases
Gene Expression
100%
Human Arteries
100%
Plasminogen Activator inhibitor-1 (PAI-1)
100%
Endothelial Cells
18%
Same Patient
9%
Clinical Conditions
9%
Thrombosis
9%
In Situ Hybridization
9%
Atherogenesis
9%
Plaque
9%
Atherosclerotic Lesions
9%
Northern Blot
9%
Normal Human
9%
Reconstructive Surgery
9%
Intima
9%
Atherosclerotic Disease
9%
Tissue Plasminogen Activator (t-PA)
9%
Fibrin Deposition
9%
Adventitial
9%
Atherosclerotic Artery
9%
Aortic Tissue
9%
Fibrinolytic Capacity
9%
Aneurysmal Disease
9%
Aortoiliac Occlusive Disease
9%
Densitometric Scanning
9%
Medicine and Dentistry
Gene Expression
100%
Artery
100%
Plasminogen Activator Inhibitor-1
100%
Disease
18%
Scanning Electron Microscopy
18%
Endothelial Cell
18%
Atherosclerosis
18%
Base
9%
Thrombosis
9%
in Situ Hybridization
9%
Reconstructive Surgery
9%
Northern Blotting
9%
Autoradiograph
9%
Atherogenesis
9%
Tissue Plasminogen Activator
9%
Fibrin Deposition
9%
Densitometry
9%
Aortic Tissue
9%
Immunology and Microbiology
Gene Expression
100%
Artery
100%
Scanning Electron Microscopy
40%
Atherosclerosis
40%
Northern Blotting
20%
Normal Human
20%
Tissue Section
20%
in Situ Hybridization
20%
Fibrin Deposition
20%
Aortic Tissue
20%